AVITA Medical shares surge 13.29% after-hours following announcement to present at Cantor Global Healthcare Conference.

Avita Medical Inc. (NASDAQ: RCEL) surged 13.29% in after-hours trading, driven by its announcement to present at the Cantor Global Healthcare Conference and increased institutional investor interest, with a 49% stake reportedly capturing market attention. Recent analyst upgrades, including Cantor Fitzgerald’s overweight recommendation and Piper Sandler’s raised price target to $23, further reinforced positive sentiment. The stock’s rally aligns with broader momentum from FDA approvals for its RECELL system and strategic updates, including automation device enhancements, which have bolstered confidence in its regenerative medicine platform.